Metraipolis › archive › dc_f49cbfebed41

Therapeutic Potential of Wogonin-Aloperine Co-Amorphous for Oral Squamous Cell Carcinoma — Europe PMC PMID:41012539

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41012539
DOI: 10.3390/pharmaceutics17091204
License (as archived): solo-consultazione
Archived: 2026-11-09T22:21:18.709Z
SHA-256 of the archived text: 8af153805597f646d7289b61a56a9b9f806fe8c193149a8bf3de586e9a168002
Stable URL of this page: https://metraipolis.com/documento/dc_f49cbfebed41

How to cite

Therapeutic Potential of Wogonin-Aloperine Co-Amorphous for Oral Squamous Cell Carcinoma — Europe PMC PMID:41012539 — Europe PMC (en), https://europepmc.org/article/MED/41012539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f49cbfebed41 (Metraipolis archive dc_f49cbfebed41, sha256 8af153805597f646d7289b61a56a9b9f806fe8c193149a8bf3de586e9a168002)

BibTeX

@misc{dcf49cbfebed41,
  title = {Therapeutic Potential of Wogonin-Aloperine Co-Amorphous for Oral Squamous Cell Carcinoma — Europe PMC PMID:41012539},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012539},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f49cbfebed41; sha256 8af153805597f646d7289b61a56a9b9f806fe8c193149a8bf3de586e9a168002},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012539. Agents can read the archived copy with the MCP tool read_document.